Medication
The Food and Drug Administration warned doctors Wednesday about the risks of serious liver injury seen with propylthiouracil, a drug used to treat overactive thyroid glands or Graves' disease.
Propylthiouracil is considered second-line treatment but is used when patients can't take another drug, methimazole.
The FDA said it saw an increased risk of liver injury with propylthiouracil when compared to methimazole.
Doug
CDIstaffing.com